BA, Western Reserve University, 1967; MD, Harvard Medical School, 1971
Donald S. Burke, M.D., is Professor of International Health and Epidemiology at the Johns Hopkins Bloomberg School of Public Health, where he serves as the Associate Chair and Director of the Disease Prevention and Control Program and Director of the Center for Immunization Research. His research interests include prevention, diagnosis, and control of infectious diseases of global importance. He is Principal Investigator of an international HIV Vaccine Trial; he leads a year-long seminar series on "Vaccine Science and Policy;" and he teaches a new course on "Infectious Disease Dynamics." Professor Burke's field research focuses on the epidemiology of emerging infectious diseases. He established and directs a project on cross-species transmission of infectious diseases in rain forest populations in Cameroon, Central Africa. He also leads a multi-institional "MIDAS" research group which which develops computational simulations and predictive models of infectious disease epidemiology and evolution, focusing on influenza, dengue, measles, and bioterrorist attacks.
Honors and Awards
PROFESSIONAL HONORS AND AWARDS
Military Decorations and Awards (Colonel, Retired, US Army, after 23 years of active duty service)
National Defense Service Medal, 1973; Army Service Ribbon, 1973; Army Commendation Medal, 1975; Meritorious Service Medal, 1978; Humanitarian Service Medal, 1981; Armed Forces Reserve Medal, 1984; Overseas Ribbon, 1984; Meritorious Service Medal, First Oak Leaf Cluster, 1985; Meritorious Service Medal, Second Oak Leaf Cluster, 1986; Order of Military Medical Merit, 1989; Department of the Army "A" Proficiency Designator, Infectious Diseases, 1990; National Defense Service Medal, First Oak Leaf Cluster, 1991; Meritorious Service Medal, Third Oak Leaf Cluster, 1991; Legion of Merit, 1997.
Honors and Awards from Professional Organizations and Societies
Phi Beta Kappa, 1966 Omicron Delta Kappa, 1966 Warrion Trophy, Western Reserve University, 1967 Nathaniel A. Young Memorial Award, American Committee on Arthropod-borne Viruses, 1989. Kimble Methodology Award, Conference of Public Health Laboratorians, American Public Health Association,1989. Bailey K. Ashford Medal, American Society of Tropical Medicine and Hygiene, 1990. Sustaining Membership Lectureship, Association of Military Surgeons of the US, 1992. Elected President, American Society of Tropical Medicine & Hygiene, 1995. Golden Apple Award, Johns Hopkins School of Hygiene and Public Health, 1999. Delta Omega, Public Health Honorary Society, 2000. Elected Fellow, American Academy of Microbiology, 2000 Thomas Francis Jr. Memorial Lectureship and Medal, 2001 Elected Fellow, American Association for the Advancement of Science (Medical Science), 2003 Centennial Anniversary Lecturer, American Society of Tropical Medicine and Hygiene, 2003. Lecturer, Annual Meeting of the National Academy of Sciences, 2004
emerging infectious diseases
Cummings DAT, Schwartz IB, Billings L, Shaw LB, Burke DS. Dynamic effects of antibody dependent enhancement on the fitness of viruses. Proc Natl Acad Sci USA 102:15259-64 (2005).
Ferguson NM, Cummings DAT, Cauchemez S, Fraser C, Riley S, Meeyai A, Iamsirithworn S, Burke DS. Evaluation of the likely effectiveness of strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437:209-14 (2005).
Wolfe ND, Heneine W, Carr JK, Garcia AD, Shanmugam V, Tamoufe U, Torimiro JN, Prosser AT, Lebreton M, Mpoudi-Ngole E, McCutchan FE, Birx DL, Folks TM, Burke DS, Switzer WM. Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters. Proc Natl Acad Sci U S A 102: 7994-9 (2005).
Gilbert PB, Peterson ML, Follmann D, Francis DP, Gurwith M, Heyward WL, Hudgens MG, Jobes DV, Popovic V, Self SG, Sinangil F, Burke DS, Berman PW. Immunologic responses to rgp120 vaccine correlate with the incidence of HIV-1 infection in a phase 3 preventive HIV-1 vaccine trial. J Infect Dis 191: 666-77 (2005)
Burke DS. Lessons learned from the 1954 Field Trial of Poliomyelitis Vaccine. Clinical Trials 1: 3-5. (2004).